Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early Treatment-Resistance in First Episode Psychosis.
Fernando P, Strauss J, Wagner E, Löhrs L, Campana M, Falkai P, Hasan A, Papazova I. Fernando P, et al. Among authors: lohrs l. Pharmacopsychiatry. 2024 Nov 15. doi: 10.1055/a-2421-2411. Online ahead of print. Pharmacopsychiatry. 2024. PMID: 39547704
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders - An individual patient data meta-analysis.
Campana M, Yakimov V, Moussiopoulou J, Maurus I, Löhrs L, Raabe F, Jäger I, Mortazavi M, Benros ME, Jeppesen R, Meyer Zu Hörste G, Heming M, Giné-Servén E, Labad J, Boix E, Lennox B, Yeeles K, Steiner J, Meyer-Lotz G, Dobrowolny H, Malchow B, Hansen N, Falkai P, Siafis S, Leucht S, Halstead S, Warren N, Siskind D, Strube W, Hasan A, Wagner E. Campana M, et al. Among authors: lohrs l. Brain Behav Immun. 2024 Jul;119:353-362. doi: 10.1016/j.bbi.2024.04.011. Epub 2024 Apr 10. Brain Behav Immun. 2024. PMID: 38608742 Free article.
The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.
Krčmář L, Jäger I, Boudriot E, Hanken K, Gabriel V, Melcher J, Klimas N, Dengl F, Schmoelz S, Pingen P, Campana M, Moussiopoulou J, Yakimov V, Ioannou G, Wichert S, DeJonge S, Zill P, Papazov B, de Almeida V, Galinski S, Gabellini N, Hasanaj G, Mortazavi M, Karali T, Hisch A, Kallweit MS, Meisinger VJ, Löhrs L, Neumeier K, Behrens S, Karch S, Schworm B, Kern C, Priglinger S, Malchow B, Steiner J, Hasan A, Padberg F, Pogarell O, Falkai P, Schmitt A, Wagner E, Keeser D, Raabe FJ. Krčmář L, et al. Among authors: lohrs l. Front Psychiatry. 2023 May 5;14:1179811. doi: 10.3389/fpsyt.2023.1179811. eCollection 2023. Front Psychiatry. 2023. PMID: 37215661 Free PMC article.
Blood-brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review.
Campana M, Löhrs L, Strauß J, Münz S, Oviedo-Salcedo T, Fernando P, Maurus I, Raabe F, Moussiopoulou J, Eichhorn P, Falkai P, Hasan A, Wagner E. Campana M, et al. Among authors: lohrs l. Eur Arch Psychiatry Clin Neurosci. 2023 Dec;273(8):1693-1701. doi: 10.1007/s00406-023-01572-3. Epub 2023 Mar 4. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36869234 Free PMC article.
Optical coherence tomography reveals retinal thinning in schizophrenia spectrum disorders.
Boudriot E, Schworm B, Slapakova L, Hanken K, Jäger I, Stephan M, Gabriel V, Ioannou G, Melcher J, Hasanaj G, Campana M, Moussiopoulou J, Löhrs L, Hasan A, Falkai P, Pogarell O, Priglinger S, Keeser D, Kern C, Wagner E, Raabe FJ. Boudriot E, et al. Among authors: lohrs l. Eur Arch Psychiatry Clin Neurosci. 2023 Apr;273(3):575-588. doi: 10.1007/s00406-022-01455-z. Epub 2022 Aug 5. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35930031 Free PMC article.
Associations between aerobic fitness, negative symptoms, cognitive deficits and brain structure in schizophrenia-a cross-sectional study.
Maurus I, Röll L, Keeser D, Karali T, Papazov B, Hasan A, Schmitt A, Papazova I, Lembeck M, Hirjak D, Thieme CE, Sykorova E, Münz S, Seitz V, Greska D, Campana M, Wagner E, Löhrs L, Pömsl J, Roeh A, Malchow B, Keller-Varady K, Ertl-Wagner B, Stöcklein S, Meyer-Lindenberg A, Falkai P. Maurus I, et al. Among authors: lohrs l. Schizophrenia (Heidelb). 2022 Aug 2;8(1):63. doi: 10.1038/s41537-022-00269-1. Schizophrenia (Heidelb). 2022. PMID: 35918344 Free PMC article.
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Hasan A, Roeh A, Leucht S, Langguth B, Hansbauer M, Oviedo-Salcedo T, Kirchner SK, Papazova I, Löhrs L, Wagner E, Maurus I, Strube W, Rossner MJ, Wehr MC, Bauer I, Heres S, Leucht C, Kreuzer PM, Zimmermann S, Schneider-Axmann T, Görlitz T, Karch S, Egert-Schwender S, Schossow B, Rothe P, Falkai P. Hasan A, et al. Among authors: lohrs l. Contemp Clin Trials Commun. 2020 Jan 28;17:100537. doi: 10.1016/j.conctc.2020.100537. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32072071 Free PMC article.
[Risk factors for the development of schizophrenia].
Löhrs L, Hasan A. Löhrs L, et al. Fortschr Neurol Psychiatr. 2019 Feb;87(2):133-143. doi: 10.1055/a-0836-7839. Epub 2019 Feb 25. Fortschr Neurol Psychiatr. 2019. PMID: 30802921 German.
12 results